Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Marshall Fordyce files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- William D. Turner - $1.45M of VERA open-market activity in the last 12 months
- Joseph R. Young - $567K of VERA open-market activity in the last 12 months
- Sean Grant - $208K of VERA open-market activity in the last 12 months
- David Lee Johnson - $108K of VERA open-market activity in the last 12 months
- Jason S. Carter - $107K of VERA open-market activity in the last 12 months
- Robert Brenner - $90K of VERA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Marshall Fordyce?
Marshall Fordyce is a corporate insider, tracked as PRESIDENT AND CEO, Director of Vera Therapeutics, Inc. (VERA). InsiderAlpha holds 13 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Marshall Fordyce submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Marshall Fordyce been buying or selling stock?
Recorded transactions: 0 open-market purchases and 43 open-market sales ($11.16M) across all tracked filings.
Where can I see all of Marshall Fordyce's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Marshall Fordyce and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
